CLASS II Device recall · Reported 18 Mar 2020 · FDA Enforcement Report

FilmArray Gastronintestinal (GI) Panel recalled by BioFire Diagnostics

BioFire Diagnostics is recalling FilmArray Gastronintestinal (GI) Panel, distributed in Illinois, Kentucky, Mississippi, New Jersey. The recall was initiated on 8 Aug 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesKit Lot: 0537319 / Pouch Lot: 681619 Pouch Lot Date of Expiration 2020-05-30
Quantity recalled23 kits (690 pouches)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1451-2020
FDA event ID
84825
Recalling firm
BioFire Diagnostics, Salt Lake City, UT
Classification
Class II
Status
Terminated
Recall initiated
8 Aug 2019
FDA classified
6 Mar 2020
Reported
18 Mar 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

8 Aug 2019Recall initiated by company
6 Mar 2020Classified by FDA+211 days
18 Mar 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Complaints have been received concerning elevated rates of false negative results while using the Gastrointestinal (GI) Panel. False negative results may lead to incorrect treatment being provided which could potentially lead to more serious health events.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

FilmArray Gastronintestinal (GI) Panel, REF: RFIT-ASY-0104, 6-pack kit, UDI (01)00815381020116, CE IVD, Rx Only

Where it was distributed

US: KY, IL, NJ, MS

IllinoisKentuckyMississippiNew Jersey

Questions about this recall

Is FilmArray Gastronintestinal (GI) Panel recalled?

Yes. BioFire Diagnostics recalled FilmArray Gastronintestinal (GI) Panel on 8 Aug 2019. The recall is Class II and its status is Terminated. Recall number Z-1451-2020.

Why was it recalled?

Complaints have been received concerning elevated rates of false negative results while using the Gastrointestinal (GI) Panel. False negative results may lead to incorrect treatment being provided which could potentially lead to more serious health events.

Which lots are affected?

Kit Lot: 0537319 / Pouch Lot: 681619 Pouch Lot Date of Expiration 2020-05-30

Where was it sold?

US: KY, IL, NJ, MS

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from BioFire Diagnostics

All 44

Other Other Medical Devices recalls

All 13,771